Latest Breaking News On - Ibrutinib imbruvica - Page 1 : comparemela.com

The IRA: Reducing Inflation Or Threatening Patient Access?

Observational Study Shows Frontline Ibrutinib With/Without Rituximab Is Safe and Effective in Low-Risk Mantle Cell Lymphoma

Ibrutinib with or without rituximab was effective and tolerable in patients with previously untreated, low-risk mantle cell lymphoma.

Dr Moustafa on Standard Treatment Approaches in MCL

Muhamad Alhaj Moustafa, MD, MS, discusses standard treatments for transplant-eligible and transplant-ineligible patients with mantle cell lymphoma.

Medicare Sends Initial Price Negotiation Bids to Drugmakers

Manufacturers of 10 drugs have 30 days to accept or make a counter-offer

Americans Often Pay 3 Times More for Medicare Drugs Up for Negotiation Than Comparable Countries

Based on a comparison of prices for drugs up for Medicare price negotiations, there is a long way to go to reach the prices of 7 comparable countries.